Advertisement






Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

Right arrow Help viewing high resolution images
Right arrow Return to article

Please click here to obtain permission to reproduce this image.

Click on image to view larger version.



Figure 4 (A and B) Representative traces of the sodium-calcium exchange current elicited by voltage ramp in a myocyte from a failing placebo-treated animal (A) and a failing furosemide-treated animal (B). Basal currents are seen in black, and the current in the same cell after stimulation with 2 µM isoproterenol (ISO) are presented in red. (C) Comparison of mean ± SEM peak outward sodium-calcium exchanger currents elicited from myocytes from nonfailing controls (yellow, n = 42 cells from 11 pigs), failing placebo-treated (red, n = 40 cells from 8 pigs), and furosemide-treated animals (purple, n = 50 cells from 9 pigs). Heart failure was associated with a significantly greater peak current, but furosemide use was associated with significantly greater current compared with placebo (*different compared with both failure groups, p < 0.05; #different from placebo cells, p < 0.05). (D) Comparison of mean ± SEM ratio of peak outward sodium-calcium exchanger currents elicited in response to ISO divided by basal current from failing myocytes from placebo- and furosemide-treated animals. Furosemide use was associated with significantly less inducible current compared with placebo and nonfailing controls, consistent with a reduction in responsiveness to beta-adrenergic stimulation (*different compared with both failure groups, p < 0.05; #different from placebo cells, p < 0.05).





Right arrow Return to article

 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement